Related by context. Frequent words. (Click for all words.) 66 target lesion revascularization 64 XIENCE V demonstrated 62 coagulopathy 62 TAXUS p value 62 MACCE 61 left ventricular systolic 61 cerebral ischemia 61 Ischemic 61 neutropenia thrombocytopenia 61 intracoronary 61 TAXUS Stent 60 angina chest 60 target vessel revascularization 60 fatty acid oxidation 59 fraction LVEF 59 coagulation factors 59 hematologic toxicity 59 Ischemia 59 hepatocellular 59 serum potassium 59 tumor lysis syndrome 58 platelet inhibition 58 Intracranial 58 extrapyramidal symptoms 58 fluid overload 58 XIENCE V vs. 58 olmesartan 58 repeat revascularization 58 mechanically ventilated patients 58 nephrotoxicity 58 fibrinolysis 58 hyperkalemia 58 paclitaxel eluting stents 57 receiving VELCADE 57 reintervention 57 acute myocardial infarction AMI 57 myocardial infarction stroke 57 severe neutropenia 57 protein albumin 57 ischemic cardiomyopathy 57 Taxus Stent 57 thromboembolic 57 angina pectoris 57 infective endocarditis 57 intravitreal injections 57 fatal myocardial infarction 57 pyelonephritis 57 heparin induced thrombocytopenia 57 platelet activation 57 left ventricular dysfunction 57 hypoxemia 57 myocardial infarction MI 57 myocardial ischemia 57 serum albumin 57 hyperparathyroidism 57 irbesartan 57 sweat chloride 57 nonfatal stroke 57 tapentadol ER 57 cerebrovascular events 56 nonfatal MI 56 intracranial bleeding 56 hypercalcemia 56 annualized relapse 56 Postoperative 56 valvular 56 fluvastatin 56 NPH insulin 56 ximelagatran 56 lymphopenia 56 nonfatal myocardial infarction 56 transurethral resection 56 sustained virological response 56 lipid lowering agents 56 estimated glomerular filtration 56 nonadherence 56 revascularization procedures 56 primary percutaneous coronary 56 flow mediated dilation 56 cardiac dysfunction 56 hepatic failure 56 eplerenone 56 NYHA Class II 56 % CI #.#-#.# [007] 56 tirofiban 55 creatinine levels 55 hypocalcemia 55 coronary revascularization 55 thromboembolism 55 cerebrospinal fluid CSF 55 vasodilators 55 liver transplant recipients 55 catecholamine 55 thrombotic events 55 patients undergoing percutaneous 55 mononuclear cells 55 corticosteroid therapy 55 composite endpoint 55 hypoglycemic events 55 hematopoietic cell 55 microvascular complications